TheStreet downgraded shares of John Wiley & Sons, Inc. (NYSE:JW.A) from a b- rating to a c rating in a research note issued to investors on Thursday.

Several other equities analysts have also recently weighed in on JW.A. Zacks Investment Research cut John Wiley & Sons from a hold rating to a sell rating in a research note on Wednesday, May 24th. Stifel Nicolaus restated a hold rating and set a $54.00 price objective on shares of John Wiley & Sons in a research note on Wednesday, July 19th.

John Wiley & Sons (NYSE:JW.A) last issued its quarterly earnings data on Thursday, September 7th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.62 by $0.03. John Wiley & Sons had a net margin of 5.32% and a return on equity of 17.78%. The company had revenue of $411.40 million for the quarter, compared to the consensus estimate of $406.41 million. During the same quarter last year, the business posted $0.52 earnings per share. John Wiley & Sons’s revenue was up 1.8% on a year-over-year basis.

COPYRIGHT VIOLATION NOTICE: “John Wiley & Sons, Inc. (JW.A) Downgraded by TheStreet to “C”” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at

John Wiley & Sons Company Profile

John Wiley & Sons, Inc provides knowledge and knowledge-enabled services in the areas of research, professional practice and education. The Company operates through three segments: Research, Professional Development and Education. Through the Research segment, the Company provides digital and print scientific, technical, medical and scholarly journals, reference works, books, database services and advertising.

Receive News & Stock Ratings for John Wiley & Sons Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons Inc. and related stocks with our FREE daily email newsletter.